Akers Biosciences CEO Christopher Schreiber's 2020 pay jumps 1,909% to $1.1M

Akers Biosciences reports 2020 executive compensation

By ExecPay News

Published: October 26, 2022

Akers Biosciences reported fiscal year 2020 executive compensation information on October 26, 2022.
In 2020, five executives at Akers Biosciences received on average a compensation package of $434K, a 121% increase compared to previous year.
Average pay of disclosed executives at Akers Biosciences
Christopher C. Schreiber, Chief Executive Officer, received $1.1M in total, which increased by 1,909% compared to 2019. 54% of Schreiber's compensation, or $590K, was in stock awards. Schreiber also received $150K in bonus, $300K in salary, as well as $58K in other compensation.
Adam Kaplin, Chief Scientific Officer, received a compensation package of $361K. 67% of the compensation package, or $240K, was in option awards.
Christopher Chapman, Chief Medical Officer, earned $298K in 2020.
Howard R. Yeaton, Chief Executive Officer, received $240K in 2020, which decreases by 29% compared to 2019.
Paul Rivard, General Counsel, earned $175K in 2020.

Related executives

Christopher Chapman

Akers Biosciences

Chief Medical Officer

Adam Kaplin

Akers Biosciences

Chief Scientific Officer

Paul Rivard

Akers Biosciences

Chief Legal Officer

Howard Yeaton

Akers Biosciences

Chief Executive Officer

Christopher Schreiber

Akers Biosciences

Chief Executive Officer

You may also like

Source: SEC filing on October 26, 2022.